Novo Kidney Trial Finds Ozempic Cuts Risk Of Major Cardiac Events And Death By 24%

Novo Kidney Trial Finds Ozempic Cuts Risk Of Major Cardiac Events and Death By 24%

A recent study conducted by Novo Nordisk, a leading pharmaceutical company, has unveiled promising results regarding the efficacy of their…